Group 1: Company Overview - The company is Shandong Boyuan Pharmaceutical Chemical Co., Ltd., with stock code 301617 and abbreviation Boyuan Shares [1] - The company specializes in iodine and iodine derivatives, which are essential raw materials in medical, agricultural, industrial, and nutritional fields [2] Group 2: Iodine Market Insights - Iodine's downstream application structure includes X-ray contrast agents, pharmaceutical manufacturing, and LCD panel manufacturing, collectively accounting for approximately 63% of global consumption [2] - Major iodine production is concentrated in Chile, Japan, and the United States, with these three countries accounting for 88% of global sales [2][3] - Chilean companies alone contribute about 60% of global iodine sales, with SQM holding a 37% market share [3] Group 3: Product Portfolio - The company's inorganic iodide products include potassium iodide, potassium iodate, sodium iodide, hydrogen iodide, and cuprous iodide, primarily used in pharmaceuticals, pesticides, and optoelectronic materials [4] - The organic iodide product trimethyl iodide silane is used as a protecting agent in organic synthesis, particularly in the production of antibiotics [4] Group 4: Competitive Advantages - **Circular Development and Comprehensive Service**: The company integrates resource recycling with its main business, ensuring a stable supply of key raw materials while assisting upstream waste disposal [5] - **Technical R&D Advantage**: The company has a professional R&D team with over 30 years of industry experience and has obtained 51 patents as of June 30, 2025 [5] - **Product Quality and Customer Resources**: The company has established a comprehensive quality control system and has long-term partnerships with well-known clients, enhancing market competitiveness [6] - **Industry Position**: The company maintains a leading market position in iodides and luminescent materials, participating in the formulation of industry standards [6] - **Compliance and Safety**: The company adheres to compliance in operations, holding all necessary safety and environmental permits, which builds customer trust [6]

（编辑 楚丽君） 证券日报网讯 8月22日晚间，博苑股份发布公告称，本公司2025年半年度权益分派方案为：以公司现有 总股本133，640，000股为基数，向全体股东每10股派2.000000元人民币现金（含税）。股权登记日为 2025年8月28日，除权除息日为2025年8月29日。 ...

证券代码：301617 证券简称：博苑股份 公告编号：2025-044 山东博苑医药化学股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 山东博苑医药化学股份有限公司（以下简称"公司"）于 2025 年 5 月 15 日 召开的 2024 年年度股东会已同意授权董事会制定 2025 年中期分红方案，公司 2025 年半年度权益分派方案已获 2025 年 8 月 18 日召开的第二届董事会第十次会议审 议通过，现将权益分派事宜公告如下： 一、股东会审议通过的利润分配预案情况 共计派发现金股利人民币 26,728,000.00 元（含税），不送红股，不以资本公积 金转增股本。若利润分配方案公布后至实施前公司总股本由于可转债转股、股份 回购、股权激励行权、再融资新增股份上市等原因而发生变化的，将按照分配比 例不变的原则对分配总额进行调整，实际分派结果以中国证券登记结算有限责任 公司深圳分公司的结果为准。实施上述分配后，公司剩余可供分配利润结转到以 后年度。 生变化。 （含 1 年）的，每 10 股补缴税款 0.200000 元；持股超过 1 年的，不需补 ...

资金流向方面，今日该股主力资金净流入4704.43万元，其中，特大单净流入4318.03万元，大单资金净 流入386.40万元。近5日主力资金净流入6076.17万元。（数据宝） 博苑股份今日上涨8.61%，全天换手率37.88%，成交额5.98亿元，振幅10.64%。龙虎榜数据显示，机构 净买入184.61万元，深股通净卖出185.99万元，营业部席位合计净买入2208.20万元。 深交所公开信息显示，当日该股因日换手率达37.88%上榜，机构专用席位净买入184.61万元，深股通净 卖出185.99万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交2.42亿元，其中，买入成交额为1.32亿 元，卖出成交额为1.10亿元，合计净买入2206.83万元。 具体来看，今日上榜的营业部中，共有3家机构专用席位现身，即买三、买四、卖二、卖三，合计买入 金额4452.55万元，卖出金额4267.94万元，合计净买入184.61万元，深股通为第一大买入营业部及第一 大卖出营业部，买入金额为5102.64万元，卖出金额为5288.63万元，合计净卖出185.99万元。 博苑股份8月22日交易公开信息 | 买 ...

证券代码：301617 证券简称：博苑股份 公告编号：2025-044 山东博苑医药化学股份有限公司 2025 年半年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 【注：根据先进先出的原则，以投资者证券账户为单位计算持股期限，持股 1 个月（含 1 个月）以内，每 10 股补缴税款 0.400000 元；持股 1 个月以上至 1 年 （含 1 年）的，每 10 股补缴税款 0.200000 元；持股超过 1 年的，不需补缴税款。】 三、股权登记日与除权除息日 本次权益分派股权登记日为：2025 年 8 月 28 日，除权除息日为：2025 年 8 月 29 日。 四、权益分派对象 山东博苑医药化学股份有限公司（以下简称"公司"）于 2025 年 5 月 15 日 召开的 2024 年年度股东会已同意授权董事会制定 2025 年中期分红方案，公司 2025 年半年度权益分派方案已获 2025 年 8 月 18 日召开的第二届董事会第十次会议审 议通过，现将权益分派事宜公告如下： 一、股东会审议通过的利润分配预案情况 1、公司 2025 年半 ...

Group 1 - The chemical products sector increased by 0.83% on August 22, with Xuefeng Technology leading the gains [1] - The Shanghai Composite Index closed at 3825.76, up 1.45%, while the Shenzhen Component Index closed at 12166.06, up 2.07% [1] - Notable stock performances included Xuefeng Technology with a closing price of 9.79, up 10.00%, and ST Quantai with a closing price of 5.15, up 9.11% [1] Group 2 - The chemical products sector experienced a net outflow of 581 million yuan from main funds, while retail investors saw a net inflow of 684 million yuan [3] - The overall market sentiment showed a mixed trend with institutional investors withdrawing funds while retail investors increased their participation [3]

Market Performance - The ChiNext Index fell by 0.47%, closing at 2595.47 points, with a total trading volume of 656.375 billion yuan, an increase of 5.838 billion yuan compared to the previous trading day [2] - Among the tradable ChiNext stocks, 453 stocks closed higher, with 17 stocks rising over 10%, including Hangzhou High-tech and Beixin Source, which hit the daily limit [2] - The average turnover rate for ChiNext stocks today was 5.72%, with 45 stocks having a turnover rate exceeding 20% [2] High Turnover Stocks - The highest turnover rate was for Kexin Information, which closed up 13.17% with a turnover rate of 47.05% and a trading volume of 1.975 billion yuan [2][6] - Other notable high turnover stocks included Zhihua Power, which rose 2.54% with a turnover rate of 44.68%, and Boyuan Shares, which increased by 10.25% with a turnover rate of 40.62% [2][6] Institutional Activity - Seven high turnover ChiNext stocks appeared on the Dragon and Tiger List, with institutional participation noted in all of them [4] - Boyuan Shares saw a net institutional purchase of 37.8327 million yuan, while Beixin Source had a net purchase of 4.4452 million yuan [4] Fund Flow - Among high turnover stocks, 26 experienced net inflows of main funds, with Beixin Source leading at 825 million yuan, followed by Meiri Interactive and Sifang Precision with 356 million yuan and 333 million yuan, respectively [5] - Conversely, stocks like Chuanhuan Technology and Gaolan Shares faced significant net outflows of 227 million yuan and 177 million yuan, respectively [5] Earnings Reports - Nine high turnover stocks released semi-annual reports, with notable profit growth from Liyuan Information, Jinlu Electronics, and Tianyuan Dike, showing increases of 65.79%, 32.19%, and 13.97% in net profit, respectively [5] - Four stocks issued earnings forecasts, with three expecting profit increases, including Huacan Optoelectronics, which anticipates a net profit of -120 million yuan, reflecting a 51.30% year-on-year increase [5]

Company Overview - Company Name: Shandong Boyuan Pharmaceutical Chemical Co., Ltd [1] - Stock Code: 301617.SZ [1] - IPO Application Date: June 17, 2022 [1] - Listing Date: December 11, 2024 [1] - Industry: Chemical Raw Materials and Chemical Products Manufacturing [1] - Underwriter: Zhongtai Securities [1] Regulatory and Performance Evaluation - Disclosure Issues: The company was required to explain the omission of sales personnel numbers and ensure the accuracy of related party disclosures [1] - Listing Cycle: The average listing cycle for A-share companies in 2024 is 629.45 days, while Boyuan's cycle is 908 days, exceeding the average [2] - Underwriting Fees: The underwriting and sponsorship fees amount to 50.9165 million yuan, with a commission rate of 7.14%, lower than the average of 7.71% [3] Market Performance - First Day Performance: The stock price increased by 188.47% on the first day of listing [4] - Three-Month Performance: The stock price rose by 98.41% compared to the issue price within three months [6] Financial Metrics - Issuance Price-Earnings Ratio: The issuance P/E ratio is 15.86 times, which is 69.59% of the industry average of 22.79 times [7] - Fundraising Amount: Expected fundraising was 753 million yuan, but the actual amount raised was 713 million yuan, a decrease of 5.13% [8] - Short-Term Performance: In 2024, the company's revenue increased by 29.53% year-on-year, and net profit attributable to shareholders grew by 17.04% [9] Overall Evaluation - Total Score: Boyuan's IPO project scored 82 points, classified as Grade B [10] - Negative Factors: Issues include the need for improved disclosure quality, a lengthy listing cycle, reduced actual fundraising, and a subscription rate of 0.23% [10]

博苑股份今日上涨10.25%，全天换手率40.62%，成交额6.01亿元，振幅15.66%。龙虎榜数据显示，机构 净买入3783.27万元，深股通净买入2953.02万元，营业部席位合计净买入2247.85万元。 深交所公开信息显示，当日该股因日换手率达40.62%上榜，机构专用席位净买入3783.27万元，深股通 净买入2953.02万元。 证券时报•数据宝统计显示，上榜的前五大买卖营业部合计成交2.08亿元，其中，买入成交额为1.49亿 元，卖出成交额为5910.25万元，合计净买入8984.14万元。 （原标题：博苑股份龙虎榜数据（8月21日）） 具体来看，今日上榜的营业部中，共有5家机构专用席位现身，即买三、买四、买五、卖二、卖四，合 计买入金额6051.63万元，卖出金额2268.36万元，合计净买入3783.27万元，深股通为第一大买入营业部 及第一大卖出营业部，买入金额为5027.47万元，卖出金额为2074.45万元，合计净买入2953.02万元。 资金流向方面，今日该股主力资金净流入4468.81万元，其中，特大单净流入4849.54万元，大单资金净 流出380.73万元。近5日主力资金净流 ...

Group 1 - The chemical products sector increased by 0.71% on August 21, with Feilu Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3771.1, up 0.13%, while the Shenzhen Component Index closed at 11919.76, down 0.06% [1] - Notable gainers in the chemical products sector included Feilu Co., Ltd. with a closing price of 12.85, up 10.40%, and Boyuan Co., Ltd. with a closing price of 44.84, up 10.25% [1] Group 2 - The chemical products sector experienced a net outflow of 449 million yuan from institutional funds, while retail investors saw a net inflow of 500 million yuan [2] - The top individual stock performers in terms of net inflow included Wanhua Chemical with a net inflow of 4.24 billion yuan, while retail investors showed significant outflows in several stocks [3] - The overall trading volume and turnover in the chemical products sector reflected mixed investor sentiment, with some stocks experiencing substantial declines [2][3]